Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial

Published 2017 View Full Article

Authors

Keywords

metastatic colorectal cancer, biomarker, miR-31-3p, anti-EGFR, cetuximab

Journal

Oncotarget

Volume -, Issue -, Pages -

Publisher

Impact Journals, LLC

Online

2017-09-28

DOI

10.18632/oncotarget.21291

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.